Alternatives to Life Science Washington

Pioneering vision restoration therapies for severe retinal degenerations.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing novel male contraceptives.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Develops and distributes bioreactor technology for stem cell cultivation.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Empowering pharmaceutical researchers with advanced molecular understanding.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global biopharmaceutical company focused on oncology and neuroscience treatments.